Ryvu Therapeutics

Ryvu Therapeutics

Develop therapeutics that address clinical limitations of current treatments in oncology. Learn more

Launch date
Employees
Market cap
CAD430m
Enterprise valuation
CAD361m (Public information from Sep 2024)
Kraków Lesser Poland Voivodeship (HQ)
Authorizing premium user...